Butterfly Network (BFLY) Current Deferred Revenue (2020 - 2026)
Butterfly Network (BFLY) reported Current Deferred Revenue of $22.7 million for Q1 2026, up 47.28% on a YoY basis from $15.4 million in Q1 2025, and down 15.79% sequentially from $26.9 million in Q4 2025.
Butterfly Network (BFLY) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Current Deferred Revenue data on file, last reported at $22.7 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue rose 47.28% year-over-year to $22.7 million; the trailing twelve-month figure through Mar 2026 stood at $22.7 million (up 47.28% YoY), and the FY2025 full-year result was $26.9 million, up 66.73% from the prior year.
- Current Deferred Revenue retreated to $22.7 million in Q1 2026, from $26.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $26.9 million in Q4 2025 to a low of $13.4 million in Q1 2022.
- A 5-year average of $16.3 million and a median of $15.6 million in 2022 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue dropped 11.86% in 2023 and soared 66.73% in 2025, its largest moves.
- Tracing BFLY's Current Deferred Revenue over 5 years: stood at $15.9 million in 2022, then declined by 1.46% to $15.6 million in 2023, then gained by 3.29% to $16.1 million in 2024, then soared by 66.73% to $26.9 million in 2025, then slipped by 15.79% to $22.7 million in 2026.
- Business Quant data shows BFLY's Current Deferred Revenue at $22.7 million in Q1 2026, $26.9 million in Q4 2025, and $16.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Butterfly Network | 1.77 Bn | 1.63 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.66 Mn |
| Dec 31, 2025 | 26.91 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.39 Mn |
| Dec 31, 2024 | 16.14 Mn |
| Sep 30, 2024 | 16.43 Mn |
| Jun 30, 2024 | 14.75 Mn |
| Mar 31, 2024 | 14.46 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Sep 30, 2023 | 15.12 Mn |
| Jun 30, 2023 | 13.73 Mn |
| Mar 31, 2023 | 14.93 Mn |
| Dec 31, 2022 | 15.86 Mn |
| Sep 30, 2022 | 13.93 Mn |
| Jun 30, 2022 | 15.57 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Sep 30, 2021 | 12.02 Mn |
| Jun 30, 2021 | 10.89 Mn |